Recombinant Coagulation Factors Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032

  • Report ID: ME_0085390
  • Format: Electronic (PDF)
  • Publish Type:
  • Number of Pages: 250
Home Healthcare recombinant coagulation factors....
  • Single User $3500
  • Multi User $4500
  • Enterprise User $5500

Market Snapshot

CAGR:8.31
2023
2032

Source: Market Expertz

RND-Favicon
Study Period 2019-2032
Base Year 2023
Forcast Year 2023-2032
CAGR 8.31
Healthcare-companies
Healthcare-Snapshot

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf
Download Sample Pdf

Report Overview

Summary

Recombinant coagulation factors are plasma derived counterparts used to treat infection from viruses such as hepatitis C and the human immunodeficiency virus. In addition, recombinant coagulation factors have low risk for transmission of infectious agents.
In 2018, the global Recombinant Coagulation Factors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% between 2019 and 2026.

This report studies the Recombinant Coagulation Factors market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2026; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

This report focuses on the global top players, covered
Baxter International Inc.
Bayer AG
Biogen Idec
CSL Ltd.
Grifols International SA
Kedrion S.P.A.
Novo Nordisk A/S
Octapharma AG
Pfizer Inc.

Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa

Market segment by Type, the product can be split into
Recombinant Factor VIII
Recombinant Factor IX
Von Willebrand Factor

Market segment by Application, the market can be split into
Hospitals
Clinics
Research Organizations

The study objectives of this report are:
To study and forecast the market size of Recombinant Coagulation Factors in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recombinant Coagulation Factors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries

Available Customizations
With the given market data, offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Recombinant Coagulation Factors market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table of Contents

Recombinant Coagulation Factors Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Recombinant Coagulation Factors
1.1 Recombinant Coagulation Factors Market Overview
1.1.1 Recombinant Coagulation Factors Product Scope
1.1.2 Market Status and Outlook
1.2 Global Recombinant Coagulation Factors Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Recombinant Coagulation Factors Market by Type
1.3.1 Recombinant Factor VIII
1.3.2 Recombinant Factor IX
1.3.3 Von Willebrand Factor
1.4 Recombinant Coagulation Factors Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Research Organizations

2 Global Recombinant Coagulation Factors Competition Analysis by Players
2.1 Recombinant Coagulation Factors Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Baxter International Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 Bayer AG
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Biogen Idec
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 CSL Ltd.
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Grifols International SA
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Kedrion S.P.A.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Novo Nordisk A/S
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Octapharma AG
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Pfizer Inc.
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Recombinant Coagulation Factors Revenue (Value) (2014-2019)
3.9.5 Recent Developments

4 Global Recombinant Coagulation Factors Market Size by Type and Application (2014-2019)
4.1 Global Recombinant Coagulation Factors Market Size by Type (2014-2019)
4.2 Global Recombinant Coagulation Factors Market Size by Application (2014-2019)
4.3 Potential Application of Recombinant Coagulation Factors in Future
4.4 Top Consumer/End Users of Recombinant Coagulation Factors

5 North America Recombinant Coagulation Factors Development Status and Outlook
5.1 North America Recombinant Coagulation Factors Market Size (2014-2019)
5.2 North America Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

6 Europe Recombinant Coagulation Factors Development Status and Outlook
6.1 Europe Recombinant Coagulation Factors Market Size (2014-2019)
6.2 Europe Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

7 China Recombinant Coagulation Factors Development Status and Outlook
7.1 China Recombinant Coagulation Factors Market Size (2014-2019)
7.2 China Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

8 Rest of Asia Pacific Recombinant Coagulation Factors Development Status and Outlook
8.1 Rest of Asia Pacific Recombinant Coagulation Factors Market Size (2014-2019)
8.2 Rest of Asia Pacific Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

9 Central & South America Recombinant Coagulation Factors Development Status and Outlook
9.1 Central & South America Recombinant Coagulation Factors Market Size (2014-2019)
9.2 Central & South America Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

10 Middle East & Africa Recombinant Coagulation Factors Development Status and Outlook
10.1 Middle East & Africa Recombinant Coagulation Factors Market Size (2014-2019)
10.2 Middle East & Africa Recombinant Coagulation Factors Market Size and Market Share by Players (2018 and 2019)

11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Recombinant Coagulation Factors Market Size (Value) by Regions (2019-2025)
11.1.1 North America Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.1.2 Europe Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.1.3 China Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Recombinant Coagulation Factors Revenue and Growth Rate (2019-2025)
11.2 Global Recombinant Coagulation Factors Market Size (Value) by Type (2019-2025)
11.3 Global Recombinant Coagulation Factors Market Size by Application (2019-2025)

12 Recombinant Coagulation Factors Market Dynamics
12.1 Recombinant Coagulation Factors Market Opportunities
12.2 Recombinant Coagulation Factors Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Recombinant Coagulation Factors Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Recombinant Coagulation Factors Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Tables and Figures

Figure Recombinant Coagulation Factors Product Scope
Figure Global Recombinant Coagulation Factors Market Size (Million USD) (2014-2019)
Table Global Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Recombinant Coagulation Factors Market Share by Regions in 2018
Figure North America Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Recombinant Coagulation Factors Market Share by Type in 2018
Figure Recombinant Factor VIII Market Size (Million USD) and Growth Rate (2014-2019)
Figure Recombinant Factor IX Market Size (Million USD) and Growth Rate (2014-2019)
Figure Von Willebrand Factor Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Recombinant Coagulation Factors Market Share by Application in 2018
Table Key Downstream Customer in Hospitals
Figure Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate in Hospitals (2014-2019)
Table Key Downstream Customer in Clinics
Figure Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate in Clinics (2014-2019)
Table Key Downstream Customer in Research Organizations
Figure Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate in Research Organizations (2014-2019)
Table Recombinant Coagulation Factors Market Size (Million USD) by Players (2018 and 2019)
Figure Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure Recombinant Coagulation Factors Market Size Share by Players in 2019
Table Baxter International Inc. Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Baxter International Inc. (2014-2019)
Figure Baxter International Inc. Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Bayer AG Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Bayer AG (2014-2019)
Figure Bayer AG Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Biogen Idec Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Biogen Idec (2014-2019)
Figure Biogen Idec Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table CSL Ltd. Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of CSL Ltd. (2014-2019)
Figure CSL Ltd. Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Grifols International SA Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Grifols International SA (2014-2019)
Figure Grifols International SA Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Kedrion S.P.A. Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Kedrion S.P.A. (2014-2019)
Figure Kedrion S.P.A. Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Novo Nordisk A/S Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Novo Nordisk A/S (2014-2019)
Figure Novo Nordisk A/S Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Octapharma AG Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Octapharma AG (2014-2019)
Figure Octapharma AG Recombinant Coagulation Factors Business Revenue Market Share in 2018
Table Pfizer Inc. Basic Information List
Table Recombinant Coagulation Factors Business Revenue (Million USD) of Pfizer Inc. (2014-2019)
Figure Pfizer Inc. Recombinant Coagulation Factors Business Revenue Market Share in 20187
Table Global Recombinant Coagulation Factors Market Size (Million USD) by Type (2014-2019)
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2014
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2015
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2016
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2017
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2018
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2019
Table Global Recombinant Coagulation Factors Market Size (Million USD) by Application (2014-2019)
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2014
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2015
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2015
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2017
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2018
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Recombinant Coagulation Factors
Figure North America Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure North America Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure North America Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure Europe Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure Europe Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure Europe Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure China Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure China Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure China Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure Rest of Asia Pacific Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure Rest of Asia Pacific Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure Central & South America Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure Central & South America Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure Middle East & Africa Recombinant Coagulation Factors Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Recombinant Coagulation Factors Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Recombinant Coagulation Factors Market Size Share by Players in 2018
Figure Middle East & Africa Recombinant Coagulation Factors Market Size Share by Players in 2019
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Regions (2019-2025)
Table Global Recombinant Coagulation Factors Market Size (Million USD) by Regions (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size Share by Regions in 2019
Figure Global Recombinant Coagulation Factors Market Size Share by Regions in 2025
Figure North America Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Recombinant Coagulation Factors Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Recombinant Coagulation Factors Market Size (Million USD) by Type (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2019
Figure Global Recombinant Coagulation Factors Market Size Share by Type in 2025
Table Global Recombinant Coagulation Factors Market Size (Million USD) by Application (2019-2025)
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2019
Figure Global Recombinant Coagulation Factors Market Size (Million USD) by Application in 2025

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now letā€™s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Personalized Business Report Tailored to Your Requirements

  • Our expert analysts collaborate directly with you to comprehend your specific needs.
  • Get data on regions, segments, competitors, and vendors of your choice.
  • Information is presented in alignment with your exact preferences and formatting.
Free Sample Report

"Find new revenue generation opportunities"